INOVIO is committed to developing new, innovative medicines to fight HPV-related diseases, cancer and infectious diseases. Our goal is to deliver on the promise of DNA medicines for patients around the globe. For more information about our clinical trials, please email clinical.trials@inovio.com.
| Title | Program | Phase | Recruiting |
|---|---|---|---|
| TitleDMAbs for Prevention of COVID-19 (More Information) |
ProgramDMAb-1 and DMAb-2 | PhasePhase 1 | RecruitingNo |
| TitleINO-5401 Vaccination in BRCA1/2 Mutation Carriers (More Information) |
ProgramINO-5401 | PhasePhase 1 | RecruitingNo |
| TitleVGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions (More Information) |
ProgramVGX-3100 | PhasePhase 2 | RecruitingNo |
SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases
© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.
